Nvidia R&D increased by 14.7% to $6.32B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 58.5%, from $3.99B to $6.32B. Over 4 years (FY 2022 to FY 2026), R&D shows an upward trend with a 36.9% CAGR.
Higher spending signals a commitment to innovation and future product launches, whereas significant cuts may indicate a shift toward short-term profitability.
Research and development expenses represent the costs incurred to discover new products, improve existing technologies,...
Highly comparable across pharmaceutical and medical device peers, where R&D intensity is a key metric for long-term valuation.
research_and_development| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | Q4 '26 | Q1 '27 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.15B | $1.25B | $1.40B | $1.47B | $1.62B | $1.82B | $1.95B | $1.95B | $1.88B | $2.04B | $2.29B | $2.47B | $2.72B | $3.09B | $3.39B | $3.71B | $3.99B | $4.29B | $4.71B | $5.51B | $6.32B |
| QoQ Change | — | +8.0% | +12.7% | +4.5% | +10.4% | +12.7% | +6.6% | +0.4% | -3.9% | +8.8% | +12.5% | +7.5% | +10.3% | +13.6% | +9.7% | +9.6% | +7.4% | +7.6% | +9.6% | +17.2% | +14.7% |
| YoY Change | — | — | — | — | +40.3% | +46.5% | +38.6% | +33.2% | +15.9% | +11.8% | +17.9% | +26.3% | +45.1% | +51.5% | +47.8% | +50.7% | +46.7% | +38.9% | +38.8% | +48.4% | +58.5% |